Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Apiam Animal Health acquires leading animal consulting business in Victoria

  • In News
  • November 27, 2019
  • Alfred Chan
Apiam Animal Health acquires leading animal consulting business in Victoria

In an offer too good to refuse, owners of privately-held veterinary company Grampians Animal Health have sold the business to Apiam Animal Health (ASX: AHX) for $4.65m. 

Located in Hamilton, Victoria – the heartland of Victorian sheep farming – the purchase will see Apiam acquire the animal veterinary clinic as well as Livestock Logic, a respected animal production consultancy business which operates throughout Victoria, New South Wales and South Australia. 

Between the two businesses, Grampian Animal Health generated $4.1m revenue in FY19 which would have the acquisition price slightly higher than industry averages, but reflective of the Livestock Logic’s growth opportunity once integrated into the Apiam Group. 

“The acquisition of GAH will significantly enhance Apiam’s operations in the Western District of Victoria and leverage our asset base and infrastructure in this region,” said Apiam Managing Director, Dr Chris Richards. 

“This is a fundamental pillar of our regional expansion strategy, and will take our South West Victorian operating region to 7 clinics.

“GAH also offers Apiam new skills and expertise in sheep consulting services and parasitology diagnostics that can be further expanded through our extensive network of production animal veterinarians in other regions of Australia.” 

Terms of the acquisition will see owners of GAH accept 70% of the purchase price in cash and 30% in AHX shares with half of the shares issued to be held in escrow for 12 months, and the other half, 24 months. There is also a deferred consideration component of $300,000 subject to business performance. 

Since listing on the ASX in 2016, Apiam Animal Health has grown its national footprint to operate in 42 locations around Australia through a mix of its veterinary services, product sales and laboratory services. 

In FY19, Apiam Animal Health reported revenues of $111.7m, a rise of 4.8% from FY18 but of greater note was the increase of 48.4% on gross margins highlighting the actualisation of Group synergy from its acquisitions. 

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • AHX
  • Apiam Animal Health
  • ASX: AHX
  • Chris Richards
  • Grampian Animal Health
  • Hamilton
  • Livestock Logic
  • sheep
  • sheep farming
  • veterinarians
  • vets
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.